Aurobindo, Wyeth Settle Fight Over Generic Effexor

Law360, New York (January 7, 2011, 6:16 PM EST) -- Aurobindo Pharma Ltd. has become the latest generic-drug maker to resolve patent infringement allegations from Wyeth Inc. that are part of wide-ranging litigation over proposed copycat versions of blockbuster antidepressant and anti-anxiety drug Effexor XR.

Judge Freda L. Wolfson of the U.S. District Court for the District of New Jersey on Thursday dismissed the parties' dispute without prejudice to the right to reopen the action within 60 days if the proposed settlement is not consummated.

The court will retain jurisdiction of the matter to the extent...
To view the full article, register now.